News

A 2022 study published in the BMB Reports highlighted that while most cases of cervical cancer are due to HPV, around 3–8% ...
5 In Türkiye, a screening project to test for the incidence rate of HPV in 4.6 million women began. AtiTECH and Pharmaline became partners to take on the task of creating and supplying the PCR ...
The company showcased its unique quantitative PCR technology-based HPV diagnostic products, 'Allplex™ HPV HR Detection' and 'Allplex™ HPV28 Detection'. The Allplex™ HPV HR Detection is ...
July 12, 2022 (GLOBE NEWSWIRE) -- OmniPathology, an independent, physician-owned and operated pathology lab, today announced the launch of a new oral test for human papillomavirus (HPV ...
The most useful test for HPV is a polymerase chain reaction (PCR) test. A PCR test takes a tiny fragment of the DNA that scientists have extracted from cells in a sample of mucus and amplifies it ...
Independent physician-owned pathology lab OmniPathology launched an oral lab-developed PCR test that detects HPV. The test, which involves a throat swab, can detect 14 high-risk strains of the ...
It's a health company that uses molecular testing to detect a wide range of different diseases, pathogens and viruses from COVID-19 to HPV. "PCR methodology is 99.9% sensitive and accurate and ...
The cervical cancer incidence rate in Sarawak stands at 12.1 per 100,000 women, said Rose Foundation programme director Dr ...
Showcases Allplex™ HPV products designed to test for 14 high-risk HPV genotypes Advocates HPV testing for early diagnosis and prevention of cervical cancer Aims to accelerate the widespread adoption ...